GlassScriptPhysician profile
Lasondra Rashell Howard
NPI 1467991844
$2,561.72
in general payments reported to CMS, 2019-2025
29 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.38 · 2023: $1,149 · 2024: $1,214 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,513 · Education: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,512.56 |
| Education | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $433.48 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $293.33 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $256.49 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $213.91 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $204.40 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.40 | 2023-2024 | Jardiance |
| Dexcom, INC. | $134.31 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $117.18 | 2023-2024 | Repatha, Otezla, Prolia |
| Exact Sciences Corporation | $91.51 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $88.27 | 2023-2025 | |
| Inspire Medical Systems, INC. | $71.53 | 2023-2024 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.15 | 2023-2024 | Xifaxan, Trulance |
| Ardelyx, INC. | $49.08 | 2024 | Ibsrela |
| Sumitomo Pharma America, INC. | $35.80 | 2024 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $35.28 | 2024 | Voquezna |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $34.34 | 2023 | Quviviq |
| Irhythm Technologies, INC. | $32.49 | 2023 | Zio Xt Patch |
| Axsome Therapeutics, INC. | $31.54 | 2024 | Auvelity |
| Philips North America LLC | $27.93 | 2024 | (Ak6) Vest Therapy |
| Ironwood Pharmaceuticals, INC | $24.09 | 2024 | |
| Dynavax Technologies Corporation | $22.42 | 2023 | Heplisav-B |
| Azurity Pharmaceuticals, INC. | $19.59 | 2023 | Horizant |
| Impel Pharmaceuticals INC. | $18.11 | 2023 | Trudhesa |
| Acella Pharmaceuticals, LLC | $16.80 | 2024 | NP Thyroid 60 |
| Xeris Pharmaceuticals, INC. | $15.74 | 2025 | Keveyis |
| Currax Pharmaceuticals LLC | $15.01 | 2023 | Contrave, Onzetra Xsail |
| Lundbeck LLC | $14.16 | 2023 | Vyepti |
| Paratek Pharmaceuticals, INC. | $13.88 | 2023 | Nuzyra |
| Abbott Laboratories | $13.50 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lasondra Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.